Full Text View
Tabular View
No Study Results Posted
Related Studies
Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
This study is ongoing, but not recruiting participants.
Study NCT00006079   Information provided by National Cancer Institute (NCI)
First Received: August 3, 2000   Last Updated: September 4, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cervical Cancer
Precancerous/Nonmalignant Condition
Additional conditions recognized in this trial
Carcinoma in Situ
Cervical Intraepithelial Neoplasia
Neoplasms
Precancerous Conditions
More general conditions related to this trial
Carcinoma
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
eflornithine
More general drug interventions related to this trial
Anti-Infective Agents
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Trypanocidal Agents
Sponsors listed in this trial
M.D. Anderson Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services